We are live on ! Find out more
PFM

Parsec Financial Management Portfolio holdings

AUM $2.37B
1-Year Est. Return 4.66%
This Fund
S&P 500
This Quarter Est. Return
+3.2%
1 Year Est. Return
-4.66%
3 Year Est. Return
+70.74%
5 Year Est. Return
+68.24%
10 Year Est. Return
+198.1%
AUM
$1.61B
AUM Growth
+$36.3M
Cap. Flow
-$6.66M
Cap. Flow %
-0.41%
Top 10 Hldgs %
25.83%
Holding
258
New
11
Increased
80
Reduced
117
Closed
10

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$10.7M
2
SAP icon
SAP
SAP
+$5.08M
3
ZBH icon
Zimmer Biomet
ZBH
+$4.43M
4
HOLX
Hologic
HOLX
+$3.97M
5
MSFT icon
Microsoft
MSFT
+$3.39M

Sector Composition

Rank Sector Weight
1 Technology 15.22%
2 Financials 13.49%
3 Healthcare 11.32%
4 Consumer Staples 7.98%
5 Industrials 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVO
26
Novo Nordisk
NVO
$219B
$20.4M 1.27%
800,246
+19,016
+2% +$470K
TTE icon
27
TotalEnergies
TTE
$180B
$19.4M 1.21%
347,949
+3,686
+1% +$201K
TSM icon
28
TSMC
TSM
$2.09T
$19.4M 1.2%
495,051
-7,502
-1% -$309K
RTX icon
29
RTX Corp
RTX
$262B
$19.2M 1.19%
234,389
+6,661
+3% +$557K
UL icon
30
Unilever
UL
$133B
$18.8M 1.17%
269,701
+11,289
+4% +$766K
CVS icon
31
CVS Health
CVS
$137B
$18.8M 1.17%
344,621
+42,942
+14% +$2.31M
DES icon
32
WisdomTree US SmallCap Dividend Fund
DES
$2.19B
$18.7M 1.16%
689,804
-10,883
-2% -$298K
CVX icon
33
Chevron
CVX
$378B
$18.7M 1.16%
150,136
+770
+0.5% +$93.1K
SBUX icon
34
Starbucks
SBUX
$119B
$18.7M 1.16%
222,560
+6,755
+3% +$530K
INFY icon
35
Infosys
INFY
$45.8B
$17.9M 1.11%
1,668,947
-195,810
-11% -$2.07M
NTR icon
36
Nutrien
NTR
$32B
$17.2M 1.07%
322,235
-6,341
-2% -$331K
TD icon
37
Toronto Dominion Bank
TD
$199B
$16.4M 1.02%
280,205
-1,868
-0.7% -$105K
SCHX icon
38
Schwab US Large- Cap ETF
SCHX
$71.2B
$16M 0.99%
1,367,610
-37,116
-3% -$426K
XOM icon
39
ExxonMobil
XOM
$615B
$15.8M 0.98%
206,638
-10,641
-5% -$824K
GILD icon
40
Gilead Sciences
GILD
$165B
$15.8M 0.98%
233,743
+111,857
+92% +$7.36M
SYY icon
41
Sysco
SYY
$38.6B
$14.7M 0.91%
207,774
+3,923
+2% +$279K
HD icon
42
Home Depot
HD
$332B
$14.5M 0.9%
69,817
-1,667
-2% -$333K
KMI icon
43
Kinder Morgan
KMI
$72.5B
$14.4M 0.9%
691,053
+20,854
+3% +$421K
AMTD
44
DELISTED
TD Ameritrade Holding Corp
AMTD
$14.4M 0.9%
288,907
-3,036
-1% -$157K
PRU icon
45
Prudential Financial
PRU
$41B
$14.2M 0.88%
140,730
+1,542
+1% +$154K
UPS icon
46
United Parcel Service
UPS
$96.2B
$13.9M 0.86%
134,582
+8,043
+6% +$837K
VEA icon
47
Vanguard FTSE Developed Markets ETF
VEA
$224B
$13.7M 0.85%
329,562
+8,729
+3% +$360K
PNC icon
48
PNC Financial Services
PNC
$99.8B
$13.7M 0.85%
100,024
+1,317
+1% +$174K
SYK icon
49
Stryker
SYK
$122B
$13.4M 0.84%
65,412
-2,013
-3% -$384K
PII icon
50
Polaris
PII
$4.14B
$12.9M 0.8%
141,812
+4,609
+3% +$420K

Similar funds

Parsec Financial Management's Q2 2019 Portfolio in Review

As of Q2 2019, Parsec Financial Management held 258 positions worth $1.61B, up 2.3% from $1.57B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Parsec Financial Management's Q2 2019 filing shows 11 new, 80 increased, 117 reduced and 10 closed positions. Its largest new stake was Broadcom: 117,080 shares worth $3.37M. The largest sale was Abbott, an estimated $10.7M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

  • Parsec Financial Management's largest Q2 2019 buy was Broadcom: 117,080 shares worth $3.37M.
  • Parsec Financial Management added most to Gilead Sciences in Q2 2019, an estimated $7.36M increase.
  • Parsec Financial Management's biggest Q2 2019 reduction was Abbott, cutting an estimated $10.7M.
  • Parsec Financial Management fully exited Fluor in Q2 2019, selling an estimated $2.44M.
  • Parsec Financial Management's ten largest holdings make up 26% of its $1.61B portfolio in Q2 2019.
  • Parsec Financial Management opened 11 new positions and closed 10 in Q2 2019.
  • Parsec Financial Management's portfolio value rose 2.3% quarter-over-quarter to $1.61B.

Based on Parsec Financial Management's 13F filing for Q2 2019, filed 23 Jul 2019.